Browse comprehensive guides on diseases — evidence-based content reviewed by MyMedicPlus Medical Review Board.
206 entries
206 results
Clinical guide to myelogenous leukemia — covering chronic myeloid leukemia (CML) and acute myeloid leukemia (AML). Covers BCR-ABL1 and FLT3/NPM1 mutations, imatinib, venetoclax, and allogeneic stem cell transplantation.
Learn about myeloproliferative neoplasms including polycythemia vera, essential thrombocythemia, myelofibrosis, and CML. Explore JAK2/CALR mutations, ruxolitinib, imatinib, and allo-SCT treatment.
Comprehensive guide to neuroendocrine tumors (NETs) including carcinoid syndrome, Ga-68 DOTATATE PET, somatostatin analogs, Lu-177 DOTATATE (NETTER-1 trial), and grading by Ki-67 and mitotic count.
Comprehensive guide to non-small cell lung cancer (NSCLC) including adenocarcinoma, squamous cell carcinoma, EGFR/ALK/ROS1 targeted therapies, pembrolizumab immunotherapy, and LDCT screening for high-risk individuals.
Comprehensive guide to oral cavity cancer. Covers tobacco and alcohol risk, leukoplakia/erythroplakia precursors, squamous cell carcinoma, neck dissection, cisplatin chemoradiation, and reconstruction.
Comprehensive guide to oropharyngeal cancer. Covers HPV-16 epidemiology, p16 IHC, AJCC 8th staging, cisplatin-IMRT chemoradiation, transoral robotic surgery (TORS), and de-escalation trials.
Comprehensive guide to osteosarcoma — the most common primary bone malignancy. Learn about risk factors, symptoms, limb-salvage surgery, MAP chemotherapy, and prognosis.
Comprehensive guide to ovarian borderline tumors (low malignant potential tumors) — covering serous and mucinous subtypes, FIGO staging, fertility-sparing surgery, and long-term surveillance after treatment.
Complete guide to ovarian cancer including BRCA1/2 testing, debulking surgery, platinum-taxane chemotherapy, PARP inhibitors (olaparib, niraparib), bevacizumab, and survival outcomes.
Comprehensive guide to ovarian epithelial cancer — the most common type of ovarian malignancy — covering causes, FIGO staging, symptoms, diagnosis, and NCCN-aligned treatment including surgery, platinum-based chemotherapy, and PARP inhibitors.
Expert guide to ovarian germ cell tumors — including dysgerminoma, yolk sac tumor, and immature teratoma — covering FIGO staging, tumor markers (AFP, beta-HCG), BEP chemotherapy, and fertility-sparing surgery.
Comprehensive guide to pancreatic ductal adenocarcinoma (PDAC). Covers KRAS mutations, CA 19-9, Whipple surgery, FOLFIRINOX, gemcitabine/nab-paclitaxel, olaparib, and prognosis.
Our patient support team can guide you to the best hospitals, doctors, and treatments based on your specific needs.
Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.